Cancer-specific c-Myc mapping reveals overlooked SLK protein as treatment target
Using a photochemically driven labeling technique, a Cornell-led research group has devised a strategy for capturing cancer-specific protein–protein interactions, which could one day lead to targeted therapies for prostate, small-cell lung, pancreatic and other deadly forms of cancer.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.